Home > Insider Trading > Filing (0000200406-11-000064)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
200406	Johnson & Johnson	JNJ	Pharmaceutical Preparations (2834)	221024240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1385325	J Dominic Caruso	Johnson &Amp; Johnson One Johnson &Amp; Johnson Plaza New Brunswick NJ 08933	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-05-13	30,000	$57.30	72,110	No	4	M	Direct
Common Stock	Disposition	2011-05-13	30,000	$66.69	42,110	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-05-13	1,700	$0.00	1,700	$57.30
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2011-05-13	28,300	$0.00	28,300	$57.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2005-02-12	2012-02-10	No	4	M	Direct
0	2005-02-12	2012-02-10	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	42	Indirect	Johnson & Johnson Stock Fund in the 401(k) Savings Plan
Common Stock	225	Indirect	ESOP in the 401(k) Savings Plan

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Phantom Stock Units	$0.00			0	9,192	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	0	9,192	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $66.65 to $66.745. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson 401(k) Savings Plan as of Plan's most recent reporting date (4/30/2011).
Shares held by ESOP under the Johnson & Johnson 401(k) Savings Plan as of Plan's most recent reporting date (4/30/2011).
Phantom Stock Units held under the Issuer's Executive Incentive Plan are to be settled in cash upon the Reporting Person's Retirement (with each Phantom Stock Unit representing the fair market value of one share of Common Stock on the settlement date). Alternatively, the cash value represented by the Phantom Stock Units may be transferred by the Reporting Person into an alternative investment account under the Plan at any time.
The Phantom Stock converts into common stock on a one-for-one basis.
Awarded under Issuer's Stock Option Plan and exercisable in full starting three years from date of grant.